至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

ARID1A gene knockdown promotes neuroblastoma migration and invasion.

Neoplasma. 2017; 
Li C,Xu Z L,Zhao Z,An Q,Wang L,Yu Y,Piao
Products/Services Used Details Operation
Nucleic Acid Purification & Analysis A  shRNA target to ARID1A (1: 5’-GCCAAGGAGAGCAGAGTAA-3’, 2: 5’-GCCCTAACATGGCCAATAT-3’) and a  control scramble sequence (shCon) (5’-GATCCCCTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTT-3’) were synthesized by and purchased from Genscript (Nanjing, China) and inserted into the BamHI/ HindIII site of linearized pRNA-H1.1 vector to yield the pRNA-H1. Get A Quote

摘要

Neuroblastoma is the most common extracranial solid tumor in childhood which often acquires drug resistance and becomes aggressive phenotypes. The high-risk patients suffer from high mortality due to the limitation of the treatment strategies. ARID1A (AT-rich interactive domain-containing protein 1A), a subunit of SWI/SNF complexes, is considered as a tumor suppressor in many cancers. The aim of the present study was to investigate the effect of ARID1A on migration and invasion in neuroblastoma cells. The shRNA targeting ARID1A was designed and delivered into SK-N-SH cells to knock down ARID1A expression. Knockdown of ARID1A by shRNA significantly increased the viability and invasion ability, and caused G... More

关键词

ARID1A,SH-N-SH cell metastasis.,neuroblastoma,s